2021
|
Question
[CLICK ON ANY CHOICE TO KNOW THE RIGHT ANSWER]
|
|
|
Cardio-vascular Disease
|
|
|
COVID-19
|
|
|
AIDS
|
|
|
Pneumococcal Disease
|
Detailed explanation-1: -Paxlovid is authorized to treat mild to moderate COVID-19 in people age 12 and older who are at higher risk of serious illness. The medications are taken by mouth as pills.
Detailed explanation-2: -In December 2022, the FDA approved tocilizumab (Actemra) as another treatment option for adults who are hospitalized with COVID-19. It’s the third medication, and the first monoclonal antibody, to be fully approved for COVID-19.
Detailed explanation-3: -Remdesivir is used to treat COVID-19 infection caused by the SARS-CoV-2 virus.
Detailed explanation-4: -Nirmatrelvir-ritonavir (Paxlovid) is an oral antiviral drug combination with activity against SARS-CoV-2. Nirmatrelvir is a protease inhibitor, which acts to inhibit viral replication by cleaving viral polyproteins involved in replication.